Aveanna Healthcare (NASDAQ:AVAH) CFO Matthew Buckhalter Sells 17,289 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 17,289 shares of the firm’s stock in a transaction dated Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02. Following the sale, the chief financial officer owned 455,320 shares of the company’s stock, valued at $3,724,517.60. This trade represents a 3.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Matthew Buckhalter also recently made the following trade(s):

• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total transaction of $143,969.00.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $145,865.28.

Aveanna Healthcare Trading Down 1.1%

Shares of AVAH stock opened at $8.08 on Friday. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The firm has a market cap of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. The company has a 50 day moving average of $8.92 and a 200-day moving average of $7.49. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $450.53 million during the quarter. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on AVAH. Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. Jefferies Financial Group boosted their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research report on Tuesday, October 28th. UBS Group raised their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a report on Friday, November 7th. BMO Capital Markets started coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price objective for the company. Finally, Raymond James Financial restated an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $10.69.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Summit Partners L P purchased a new stake in shares of Aveanna Healthcare in the second quarter worth $50,477,000. AustralianSuper Pty Ltd purchased a new position in Aveanna Healthcare during the third quarter worth about $15,743,000. Vanguard Group Inc. increased its stake in Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. Hillsdale Investment Management Inc. purchased a new stake in shares of Aveanna Healthcare in the 3rd quarter valued at about $7,922,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Aveanna Healthcare in the 3rd quarter valued at about $7,356,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.